Related Experiment Video
Updated: Mar 13, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Health-Related Quality of Life Among Adults With Inflammatory Bowel Disease in Ireland: A Cross-Sectional Study Using
Kristian P Mallon1, Glen A Doherty2, Richéal M Burns1
1Department of Health and Nutritional Science, Atlantic Technological University, Sligo, Ireland; The Health and Biomedical Research Center (HEAL), Atlantic Technological University, Sligo, Ireland.
Objectives:
Inflammatory bowel disease (IBD) is a chronic, relapsing-remitting condition that impacts both physical and mental health. The unpredictable nature of relapse and associated symptoms adds to the burden of living with IBD. This analysis seeks to understand the impact on health-related quality of life (HRQoL) of a sample of Irish individuals living with IBD.
Methods:
A cross-sectional survey was distributed to individuals living with IBD in Ireland through online study invites. Information on HRQoL was collected using the international EuroQol EQ-5D-5L questionnaire. Regression models examined associations between HRQoL and sociodemographic and clinical factors.
Results:
A total of 142 individuals living with IBD in Ireland were recruited. The mean EQ-5D-5L utility score was 0.73 (SD 0.25), ranging from -0.174 to 1. Compared with individuals aged younger than 30 years, those aged 50 years and older had significantly higher utility scores (β= 0.16; P<.001). Compared with those in remission, individuals reporting severe disease had significantly lower utility scores (β= -0.28; P<.001). An inverse association between the number of comorbidities and utility score was observed, with those reporting 2 (β = -0.14; P=.001), 3 (β = -0.17; P<.001), and 4 or more (β= -0.23; P<.001) comorbidities exhibiting significantly lower utility scores than individuals reporting no comorbidities. Individuals who felt their IBD was not well controlled had significantly lower utility scores (β= -0.16; P=.001).
Conclusions:
HRQoL varies with the severity of IBD, with individuals experiencing more severe symptoms reporting lower quality of life. These findings highlight the need for holistic, person-centered approaches to support those with IBD and improve quality of life.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
